These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 25483672)

  • 1. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
    Liu CC; Chow YH; Chong P; Klein M
    Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
    Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
    Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Li YX; Zhu SY; He YL; Qin ED; Chen R; Qin CF
    Appl Microbiol Biotechnol; 2013 Dec; 97(24):10445-52. PubMed ID: 24085395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
    Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
    Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
    Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
    Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal injection of a fractional dose of an inactivated HFMD vaccine elicits similar protective immunity to intramuscular inoculation of a full dose of an Al(OH)
    Li M; Duan Y; Yang X; Yang Q; Pang B; Wang Y; Ren T; Wang X; Zhao Z; Liu S
    Vaccine; 2017 Jun; 35(30):3709-3717. PubMed ID: 28576572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
    Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z
    Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
    Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
    Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
    Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge.
    Liu Q; Yan K; Feng Y; Huang X; Ku Z; Cai Y; Liu F; Shi J; Huang Z
    Vaccine; 2012 Oct; 30(47):6642-8. PubMed ID: 22959985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.
    Li J; Liu G; Liu X; Yang J; Chang J; Zhang W; Yu XF
    Viruses; 2015 Jul; 7(7):3891-909. PubMed ID: 26193302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.